Allergan

Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.
Company Growth (employees)
Type
Public
HQ
Dublin, IE
Founded
1948
Size (employees)
16,700 (est)-46%
Allergan was founded in 1948 and is headquartered in Dublin, IE

Key People/Management at Allergan

Robert Stewart

Robert Stewart

Chief Operating Officer
Brenton Saunders

Brenton Saunders

Chairman of the Board of Directors, Chief Executive Officer and President
William Meury

William Meury

Chief Commercial Officer

Allergan Office Locations

Allergan has offices in Dublin and Parsippany-Troy Hills
Parsippany-Troy Hills, US
400 Interpace Pkwy

Allergan Financials and Metrics

Allergan Financials

USD

Market capitalization (10-Oct-2017)

69.3 b

Closing share price (10-Oct-2017)

202.9

Cash (31-Dec-2014)

4.9 b

EV

66.6 b
Allergan's current market capitalization is $69.3 b.
USDFY, 2013FY, 2014

Cash

3 b4.9 b

Accounts Receivable

883.3 m914.5 m

Inventories

285.3 m296 m

Current Assets

5.3 b6.9 b
USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m

Inventories

(27 m)(44 m)

Accounts Payable

37.4 m1.9 m
Y, 2014

EV/CFO

34.5 x

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

1.6 x
Show all financial metrics

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
ZELTIQ Aesthetics (CoolSculpting)February 15, 2017$2.5 b

Allergan Market Value History

Allergan Median Salaries

Source: 108 public H-1B filings from Allergan

Traffic Overview of Allergan

Allergan Online and Social Media Presence

Allergan News and Updates

Allergan loses Restasis patent protections in federal court decision

After stirring up a tribal licensing controversy, Allergan has run into a patent setback with big-selling eye medication Restasis. A federal judge invalidated exclusive protections for the drug—Allergan's second biggest—boosting prospects for generic companies looking to challenge the branded drug's…

'Sham' or legit? Texas judge set to weigh in on Allergan's tribal patent deal

Marking the latest twist in a bitter Restasis patent fight, Mylan and other generic drugmakers urged a Texas judge to decide that Allergan's patent deal with the Saint Regis Mohawk Tribe is a "sham."

Europe Facial Injectable industry is Projected to grow at a CAGR of 13.5% by Forecast to 2021

Market research future has a cooked research report on Europe Facial injectable market. The Europe market for Facial injectable is growing at a rapid pace and expected to reach around USD 2,988.0 Million by the end of the forecasted period 2016-2021 Posted via Industry Today. Follow us on Twitter @I…

Allergan settles Restasis litigation with Pfizer's InnoPharma as backlash mounts over tribal patent deal

Allergan inked a settlement that gets one more would-be generic challenger off its radar, for now.

Breast Implants Market will grow at moderate CAGR to reach $4.5 Billion by 2024

Breast Implants Market By Product (Silicone Implant, Saline Implant), By Shape (Round, Anatomical), By Application (Breast Augmentation, Breast Reconstruction), By End Use (Hospitals, Clinics, Others), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russi…

Bipolar Disorders and Treatment Market Segments, Key Players Strategies, Analysis and Forecasts Till 2022

The World Bipolar Disorders and Treatment Market analyzed by the basis of treatment include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and others. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Allergan Company Life and Culture

You may also be interested in